Research ArticleArticle
Effects of Macitentan and Its Active Metabolite on Cultured Human Systemic Sclerosis and Control Skin Fibroblasts
Maurizio Cutolo, Paola Montagna, Renata Brizzolara, Vanessa Smith, Elisa Alessandri, Barbara Villaggio, Alberto Sulli, Pietro Paolo Tavilla, Carmen Pizzorni and Stefano Soldano
The Journal of Rheumatology March 2015, 42 (3) 456-463; DOI: https://doi.org/10.3899/jrheum.141070
Maurizio Cutolo
From Research Laboratory and Academic Division of Clinical Rheumatology, Research Laboratory of Nephrology, Department of Internal Medicine, and the Department of Health Science, Unit of Dermatology, University of Genoa, Genoa,
Italy; and the Department of Rheumatology, Ghent University Hospital, Ghent,
Belgium.
Paola Montagna
Renata Brizzolara
Vanessa Smith
Elisa Alessandri
Barbara Villaggio
Alberto Sulli
Pietro Paolo Tavilla
Carmen Pizzorni
Data supplements
Data Supplement
Data Supplement
Files in this Data Supplement:
- Data Supplement - Data Supplement
In this issue
The Journal of Rheumatology
Vol. 42, Issue 3
1 Mar 2015
Effects of Macitentan and Its Active Metabolite on Cultured Human Systemic Sclerosis and Control Skin Fibroblasts
Maurizio Cutolo, Paola Montagna, Renata Brizzolara, Vanessa Smith, Elisa Alessandri, Barbara Villaggio, Alberto Sulli, Pietro Paolo Tavilla, Carmen Pizzorni, Stefano Soldano
The Journal of Rheumatology Mar 2015, 42 (3) 456-463; DOI: 10.3899/jrheum.141070
Effects of Macitentan and Its Active Metabolite on Cultured Human Systemic Sclerosis and Control Skin Fibroblasts
Maurizio Cutolo, Paola Montagna, Renata Brizzolara, Vanessa Smith, Elisa Alessandri, Barbara Villaggio, Alberto Sulli, Pietro Paolo Tavilla, Carmen Pizzorni, Stefano Soldano
The Journal of Rheumatology Mar 2015, 42 (3) 456-463; DOI: 10.3899/jrheum.141070